Dr. Friedman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce Street
Philadelphia, PA 19104Phone+1 215-662-6932Fax+1 215-662-7899- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemFellowship, Infectious Disease, 1973 - 1975
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1973 - 1975
- McGill University Faculty of MedicineClass of 1969
Certifications & Licensure
- PA State Medical License 1973 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1986
Clinical Trials
- Pilot Study of Text Message Reminders to Improve HIV Medication Adherence in Botswana Start of enrollment: 2008 Jun 01
Publications & Presentations
PubMed
- 2 citationsRapid and accurate detection of herpes simplex virus type 2 using a low-cost electrochemical biosensor.Lucas F de Lima, André L Ferreira, Sita Awasthi, Marcelo D T Torres, Harvey M Friedman, Gary H Cohen, William R de Araujo, Cesar de la Fuente-Nunez> ;Cell Reports. Physical Science. 2023 Sep 20
- 1 citationsA Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparabl...Kevin P Egan, Sita Awasthi, Giulia Tebaldi, Lauren M Hook, Alexis M Naughton, Bernard T Fowler, Mitchell Beattie, Mohamad-Gabriel Alameh, Drew Weissman, Gary H Cohen, ...> ;Viruses. 2023 Jun 30
- Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeu...Sita Awasthi, Motoyasu Onishi, John M Lubinski, Bernard T Fowler, Alexis M Naughton, Lauren M Hook, Kevin P Egan, Masaki Hagiwara, Seiki Shirai, Akiho Sakai, Takayuki ...> ;Viruses. 2023 May 10
- Join now to see all
Other
- The epidemiology, pathogenesis, and clinical manifestations of smallpoxFriedman HM, Isaacs SN
http://www.uptodate.com/contents/the-epidemiology-pathogenesis-and-clinical-manifestations-of-smallp
UpToDate, Wolters Kluwer Health - 2012-03-26 - Vaccinia virus in the research settingFriedman HM, Isaacs SN
http://www.uptodate.com/contents/vaccinia-virus-in-the-research-setting
UpToDate, Wolters Kluwer Health - 2012-03-20 - Vaccinia virus as the smallpox vaccineFriedman HM, Isaacs SN
http://www.uptodate.com/contents/vaccinia-virus-as-the-smallpox-vaccine
UpToDate, Wolters Kluwer Health - 2013-03-18
Press Mentions
- Race to Develop mRNA Flu Vaccines Will Contend with a Longer Review Than Covid-19August 11th, 2021
- After Covid-19, mRNA Technology Aims to Revolutionise the Flu ShotAugust 10th, 2021
- How mRNA Vaccines Could Prevent or Eliminate Infectious Diseases Beyond COVID-19June 15th, 2021
- Join now to see all
Grant Support
- InternationalNational Institute Of Allergy And Infectious Diseases2009–2011
- Blocking Immune Evasion As A Novel HSV Vaccine ApproachNational Heart, Lung, And Blood Institute2008–2010
- Postdoctoral Training Grant In Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2001–2010
- Herpes Simplex Virus FC ReceptorNational Institute Of Allergy And Infectious Diseases1992–2009
- Blocking Immune Evasion As A Nevel HSV Vaccine ApproachNational Heart, Lung, And Blood Institute2007
- Virus &Immune Injury To Vessel Wall CellsNational Heart, Lung, And Blood Institute1991–2006
- Protease Inhibitor-Sparing Regimens For The Initial Treatment Of HIV SubjectsNational Center For Research Resources2005
- Cryopreservation Evaluation In HIV SubjectsNational Center For Research Resources2005
- Comparison Of Lopinavir/Ritonavir PLUS Efavirenz Versus Lopinavir/RitonavirNational Center For Research Resources2005
- Beta-D-2, Dapd, Versus DAPD PLUS MMF In Treatment HIV SubjectsNational Center For Research Resources2005
- ACTG A5116: Simplified Regimens Regimen VS A Nucleoside-Sparing RegimenNational Center For Research Resources2005
- ACTG A5001: Adult AIDS Clinical Trials Group Longitudinal Linked TrialsNational Center For Research Resources2005
- Herpes Simplex Virus Immune Evasion In HIV SubjectsNational Institute Of Dental &Craniofacial Research2001–2005
- Lopinavir/Ritonavir PLUS Efavirenz Versus Lopinavir/RitNational Center For Research Resources2004
- HIV Infected Subjects WHO Have 200 HIV-1 RNA Copies/MlNational Center For Research Resources2004
- Beta-D-2,6-Diaminopurine Dioxolane Versus DAPD PLUS Mycophenolate MofetilNational Center For Research Resources2004
- Adult AIDS Clinical Trials Group Longitudinal Linked Randomized TrialsNational Center For Research Resources2004
- 3 Protease Inhibitor-Sparing Regimens For The Initial Treatment Of HIV InfectionNational Center For Research Resources2004
- Sb-265805 Compared With Cefuroxime Axetil In Acute SinusNational Center For Research Resources2000–2002
- Core--Clinical FacilityNational Institute Of Allergy And Infectious Diseases1999–2002
- ACTG 892: Effect Of Highly Active Antiretroviral Therapy On Lean BodyNational Center For Research Resources1999–2002
- ACTG 383:Subjects W/ Hepatitis C Virus &Human Immunodeficiency VirusNational Center For Research Resources1999–2002
- HSV 007--Skbs HSV Vaccine To Prevent Genital Herpes In Healthy SubjectsNational Center For Research Resources1998–2002
- ACTG 360-- Prospective Study Of HIV Wrt CMV Burden Endorgan DiseaseNational Center For Research Resources1998–2002
- Hsv107--Herpes Simplex Vaccine (GD2T) In HSV + Or - Consorts With Genital HerpesNational Center For Research Resources1997–2002
- AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1996–2002
- HSV 16--Herpes Simplex Candidate Vaccine With MPL In HSV PTS W/O Genital HerpesNational Center For Research Resources1997–2000
- Virus And Immune Injury To Vessel Wall CellsNational Heart, Lung, And Blood Institute1987–2000
- Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases1997–1999
- Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases1997–1999
- Outreach AgendaNational Institute Of Allergy And Infectious Diseases1997–1999
- Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases1997–1999
- Neurology AgendaNational Institute Of Allergy And Infectious Diseases1997–1999
- Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases1997–1999
- HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases1997–1999
- Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases1997–1999
- Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases1997–1999
- Herpes Simplex Virus FC ReceptorNational Institute Of Allergy And Infectious Diseases1997
- HSV 007--Skbs HSV Vaccine To Prevent Genital Herpes In Healthy SubjectsaNational Center For Research Resources1997
- Actg229--Ro31 8959 PLUS Zidovudine VS Zidovudine PLUS DDCNational Center For Research Resources1997
- ACTG 244--Condon 215 Mutation In Zvd Monotherapy/Maintenance TherpyNational Center For Research Resources1997
- ZDV VS ZDV + Ddl VS ZDV + Ddl + NVP In Asymptomatic HIV PatientsNational Center For Research Resources1996
- Actg229--Ro31-8959 PLUS Zidovudine VS Zidovudine PLUS ZalcitabineNational Center For Research Resources1996
- AIDS Clinical TrialNational Institute Of Allergy And Infectious Diseases1994–1995
- AIDS Clinical Trial UnitNational Institute Of Allergy And Infectious Diseases1992–1993
- Steroid Regulation Of HSV 1 Glycoprotein C ExpressionFogarty International Center1986
- Virus And Immune Injury To Vessel Wall CellsNational Heart, Lung, And Blood Institute1985–1986
Hospital Affiliations
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: